Jpn. J. Pharmacol. 74 (2), 209-212 (1997)
The Selective 5-Hydroxytryptamine (5-HT)4-Receptor Agonist RS67506 Enhances
Lower Intestinal Propulsion in Mice
Yukinori Nagakura, Hiroyuki Ito, Tetsuo Kiso, Yuki Naitoh and Keiji Miyata
Neuroscience Research, Pharmacological Laboratories, Institute for Drug
Discovery Research, Yamanouchi Pharmaceutical Co., Ltd., 21 Miyukigaoka,
Tsukuba, Ibaraki 305, Japan
Abstract: Interactions of gastrointestinal prokinetic benzamides
with 5-hydroxytryptamine (5-HT)3 and 5-HT4 receptors and the relation to
their effects on gastrointestinal propulsion were investigated. Renzapride
and zacopride potently inhibited 5-HT3-receptor-mediated contractions in
the guinea pig colon, whereas RS67506 (1-(4-amino-5-chloro-2-methoxyphenyl)-3-[1-(2-methyl
sulphonylamino)ethyl-4-piperidinyl]-1-propanone hydrochloride), a selective
5-HT4-receptor agonist, showed no inhibition. RS67506, renzapride and zacopride
all exerted 5-HT4 receptor-mediated relaxation in the carbachol-precontracted
rat oesophagus. In mice, RS67506 shortened the whole gut transit time, whereas
renzapride and zacopride were reported to prolong it. Gastrointestinal prokinetic
benzamides, which are selective for 5-HT4-receptor agonistic over 5-HT3-receptor
antagonistic action, may be useful in treating gastrointestinal disorders
associated with impaired lower intestinal propulsion such as constipation.
Keywords: 5-HT3 receptor, 5-HT4 receptor, RS67506
Copyright© The Japanese Pharmacological Society 1997
[Back to TOC]